11:00 - 12:00

Medical Device Patent Litigation in Europe and Israel: Success-Oriented Strategies

​

• Commercial potential of patent litigation in the medical device space;

• Key aspects of patent litigation in Israel versus Germany, the Netherlands and the UK;

• Planning ahead - how to aim at getting a preliminary injunction, final injunction, cross border injunction and other remedies;

• Tips and tricks for success.

• Q&A

​

​

Miriam Gundt:

Miriam is a specialist for the coordination of international patent disputes and the enforcement of intellectual property rights in various jurisdictions. Focusing on the pharma and biotech industry, life science and medical engineering, her strategic advice comprises questions regarding the Unified Patent Court (UPC) and the European Patent with Unitary Effect. She represents and advises our clients in all matters of intellectual property and technical industrial property rights. Miriam is an expert in the area of interim legal protection, including preliminary injunctions and evidence seizures. She has successfully obtained and enforced or defended against preliminary injunctions for various clients.

Ruud van der Velden:

Ruud has 15 years’ experience in multi-jurisdictional patent and trade secret litigation. He litigates before all Courts in the Netherlands and the EPO and represents companies in all technological fields, with a particular focus on life sciences and medical devices. Besides litigation, Ruud also works with clients on their patent and trade secret protection strategies, in order to improve their success in the market and, if necessary, in court. Ruud has particular experience in cross-border injunctions and evidence collection measures.

Stella Wong:

Stella is dual qualified as a medical doctor and a solicitor and is a counsel in the intellectual property team of Hogan Lovells’ London office. Stella specializes in complex multi-jurisdictional patent litigation and patent strategies, with a focus on medical device, pharmaceutical and biotechnology patents.​

Asa Kling:

Asa Kling heads the firm’s IP practice. His practice focuses on litigation and transactional issues pertaining to all aspects of intellectual property. 
Mr Kling provides clients with insights into the operations of IP offices, especially where cutting edge technologies such as blockchain, AI, IoT and software implemented inventions are concerned. 
Prior to joining the firm, Mr Kling was the director of the Israel Patent Office and Commissioner of Patents, Trademarks and Designs (2011- 2017). Mr Kling is well-recognised as a leading litigator in courts, arbitrations, mediations and proceedings at the Israel Patent Office which he presided. He has gained a unique perspective on special IP litigation matters, such as patent term extensions, patent and trademark validity, design rights under the new Israeli Design Law, service inventions and trade secrets. 
Mr Kling is a regular speaker in many international forums. He teaches IP law in several academic institutes.